Letter to the Editors: "Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination" by C. Schwab et al
- PMID: 37097462
- PMCID: PMC10126539
- DOI: 10.1007/s00392-023-02198-0
Letter to the Editors: "Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination" by C. Schwab et al
Conflict of interest statement
The authors have no competing interests to declare that are relevant to the content of this article.
Comment on
-
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination.Clin Res Cardiol. 2023 Mar;112(3):431-440. doi: 10.1007/s00392-022-02129-5. Epub 2022 Nov 27. Clin Res Cardiol. 2023. PMID: 36436002 Free PMC article.
-
Commentary on: "Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination" by C. Schwab et al.Clin Res Cardiol. 2024 Feb;113(2):353-355. doi: 10.1007/s00392-023-02197-1. Epub 2023 Apr 25. Clin Res Cardiol. 2024. PMID: 37097464 Free PMC article. No abstract available.
References
-
- Ameratunga R, Woon ST, Sheppard MN, Garland J, Ondruschka B, Wong CX, et al. First identified case of fatal fulminant necrotizing eosinophilic myocarditis following the initial dose of the Pfizer-BioNTech mRNA COVID-19 vaccine (BNT162b2, Comirnaty): an extremely rare idiosyncratic hypersensitivity reaction. J Clin Immunol. 2022;42(3):441–447. doi: 10.1007/s10875-021-01187-0. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
